ELEGEN Trademark

Trademark Overview


On Wednesday, March 1, 2023, a trademark application was filed for ELEGEN with the United States Patent and Trademark Office. The USPTO has given the ELEGEN trademark a serial number of 97818387. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, April 1, 2024. This trademark is owned by Elegen Corp.. The ELEGEN trademark is filed in the Pharmaceutical Products category with the following description:

Nucleic acid for pharmaceutical and medical diagnostic use
elegen

General Information


Serial Number97818387
Word MarkELEGEN
Filing DateWednesday, March 1, 2023
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, April 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesNucleic acid for pharmaceutical and medical diagnostic use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 21, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameElegen Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Carlos, CA 94070

Trademark Events


Event DateEvent Description
Monday, April 1, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, April 1, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, December 5, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 5, 2023NON-FINAL ACTION E-MAILED
Tuesday, December 5, 2023NON-FINAL ACTION WRITTEN
Wednesday, November 29, 2023ASSIGNED TO EXAMINER
Tuesday, March 21, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 4, 2023NEW APPLICATION ENTERED